Vigilance Santé: a new single shareholder

Repentigny, September 10, 2024 – Vigilance Santé is proud to announce that Andrée-Anne Chevalier, President since 2020 and daughter of founder Raymond Chevalier, has now become the sole shareholder and President of the company her father founded over 30 years ago. This generational transition is not only guided by a clear vision for growth and innovation but also stays true to the company's heritage, ensuring the continuity of the values and mission that have driven its success.

Through the development of innovative reference and analysis software focused on drug therapy, Vigilance Santé has become an invaluable asset for its partners as well as front-line healthcare professionals across Canada. In addition to expanding the company's presence in Canada, Ms. Chevalier is committed to launching an ambitious effort to enter the U.S. market in the coming years.

“I'm honored to follow in my father's footsteps and lead Vigilance Santé forward, while staying true to our family roots. We are ready to take on future challenges with the same passion and commitment that have driven our success over the years,” said Andrée-Anne Chevalier.

“I'm delighted to know that Vigilance Santé will continue to grow and develop under the guidance of a skilled and inspiring manager, and that the company I built will be ready to soar on its own wings, supported by a dynamic and extremely knowledgeable team” , mentioned Raymond Chevalier.

Vigilance Santé will continue to develop solutions that meet the needs of healthcare professionals, while exploring new business opportunities and markets, and further strengthening its commitment to excellence.

About Vigilance Santé

Founded in 1991 by pharmacist Raymond Chevalier, Vigilance Santé's mission is to combine knowledge, intelligence and technology to empower frontline healthcare professionals. To this end, the company develops innovative products and services centred around drug therapy. Renowned for its rigour, professionalism and commitment to evolving with the needs of the industry, Vigilance Santé has earned a reputation as a trusted partner to both customers and collaborators.

The Flagship Product

RxConsultAction | This application guides pharmacists step-by-step in performing and documenting their clinical acts, all within their pharmacy software. We are excited to announce that it will be available in all Canadian provinces by the end of 2024. RxConsultAction

RxVigilance | This software is a first-line reference and the ideal assistant when it comes to making informed clinical decisions regarding Canadian medications. RxVigilance

For more informations : 1 844 582-3917 ou info@vigilance.ca Follow Vigilance Santé on Facebook et LinkedIn